Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "A 37-year-old woman presenting with impaired visual function during antituberculosis drug therapy: a case report"

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: A 37-year-old woman presenting with impaired visual function during antituberculosis drug therapy: a case report. | Ayanniyi and Ayanniyi Journal of Medical Case Reports 2011 5 317 http www.jmedicalcasereports.eom content 5 1 317 JOURNAL OF MEDICAL CASE REPORTS CASE REPORT Open Access A 37-year-old woman presenting with impaired visual function during antituberculosis drug therapy a case report Abdulkabir A Ayanniyi1 2 and Rashidat O Ayanniyi3 Abstract Introduction Combination antituberculosis drug therapy remains the mainstay of treating tuberculosis. Unfortunately antituberculosis drugs produce side effects including toxic impaired visual function which may be irreversible. We report a case of antituberculosis-drug-induced impaired visual function that was reversed following early detection and attention. Case presentation A 37-year-old Yoruba woman weighing 48 kg presented to our facility with impaired visual functions and mild sensory polyneuropathy in about the fourth month of antituberculosis treatment. Her therapy comprised ethambutol 825 mg isoniazid 225 mg rifampicin 450 mg and pyrazinamide 1200 mg. Her visual acuity was 6 60 in her right eye and 1 60 in her left eye. She had sluggish pupils red-green dyschromatopsia hyperemic optic discs and central visual field defects. Her intraocular pressure was 14 mmHg. Her liver and kidney functions were essentially normal. Screening for human immunodeficiency virus was not reactive. Her impaired visual function improved following prompt diagnosis and attention including the discontinuation of medication. Conclusions The ethambutol and isoniazid in antituberculosis medication are notorious for causing impaired visual function. The diagnosis of ocular toxicity from antituberculosis drugs should never be delayed and should be possible with the patient s history and simple but basic eye examinations and tests. Tight weight-based antituberculosis therapy routine peri-therapy visual function monitoring towards early detection of impaired function and prompt attention will reduce avoidable ocular morbidity. Introduction Tuberculosis is

TÀI LIỆU LIÊN QUAN
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.